Fingerprint
Dive into the research topics of 'Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically